Tag: BIIB

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Biogen Receives FDA Approval for Alzheimer’s Drug

Rebecca Urena06/07/202106/07/2021

2619

On Monday, The Food and Drug Administration, approved Biogen’s (NASDAQ: BIIB) Alzheimer’s disease drug aducanumab. The medication, which delays the cognitive decline in patients with Alzheimer’s, is the first...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Biogen and Sage Therapeutics Collaborate to Develop and Commercialize Potential Therapies in Depression and Movement Disorders

Danny Abramov11/27/2020

18344

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) have collaborated to develop and commercialize zuranolone and SAGE-324. Zuranolone is used to treat postpartum depression, major depressive disorder...

Tag: BIIB

Biogen Receives FDA Approval for Alzheimer’s Drug

Biogen and Sage Therapeutics Collaborate to Develop and Commercialize Potential Therapies in Depression and Movement Disorders

ABOUT US

Tweets